1. Introduction {#sec1}
===============

Genomic imprinting, in which the monoallelic expression of certain genes depends on the parent of origin due to epigenetic regulation in somatic cells, is vital for fetal growth and development, function of the placenta, and postnatal behaviour in mammals. Many researches have reported that disruption of genomic imprinting is responsible for congenital disorders, cancers, and other types of diseases such as BWS (Beckwith-Wiedemann syndrome) and PWS (Prader-Willi syndrome) \[[@B1]--[@B4]\]. Currently, about 2114 imprinted transcripts and 600 potentially imprinted genes have been estimated in the genome of mice \[[@B5], [@B6]\], of which about 160 imprinted genes have been described (<http://igc.otago.ac.nz/home.html>), but only several genes have been reported to be imprinted in pigs. Therefore, it is necessary to characterize more imprinted genes in the pig to offer new data and insights to the comparative genome research as well as porcine functional genomics.

Most imprinted genes aggregate within the genome and gene order and imprinting in each imprinted domain show considerable similarity between mouse and human \[[@B7], [@B8]\]. It has been reported that CDKN1C and KCNQ1OT1 reside in an imprinted cluster on human 11p15.5, syntenic to mouse distal chromosome 7. Genes in this region include OSBPL5, CARS, NAP1L4, PHLDA2, SLC22A18, SLC22A18AS, CDKN1C, KCNQ1DN, KCNQ1OT1, KCNQ1, TSSC4, CD81, and ASCL2 \[[@B8]\]. Imprinting disruption of the CDKN1C/KCNQ1OT1 domain is involved in the development of both BWS and cancer \[[@B8]\].

CDKN1C (cyclin-dependant kinase inhibitor) and NAP1L4 (nucleosome assembly protein 1-like 4) are two of particular interest genes within the CDKN1C/KCNQ1OT1 imprinted cluster in human and mouse. The CDKN1C, also known as p57^Kip2^, encodes a cyclin-dependent kinase inhibitor (CDKI) that belongs to the CIP/KIP family, and it is a putative tumor suppressor gene \[[@B9], [@B10]\]. Mutations in CDKN1C have been identified in approximately 5--20% of patients with BWS \[[@B11], [@B12]\], and mice with maternally inherited deletion of CDKN1C showed some features of BWS \[[@B13]\], while in sporadic cancers and embryonal tumors, mutations of CDKN1C are very rare \[[@B14]--[@B18]\]. NAP1L4, also called NAP-2, codes for a protein with homology to NAPs involved in regulating gene expression by delivering histones from the cytoplasm to the chromatin assembly machinery \[[@B19]\]. NAP1L4 associates with the processes of restraining fetal growth and causing fetal lethality \[[@B20]\]. These results suggest that CDKN1C and NAP1L4 are two of the important genes responsible for the development of BWS and cancer \[[@B8]\].

At present, there are a lot of reports about the imprinting status of CDKN1C and NAP1L4 both in human and mouse. CDKN1C is expressed from the maternal allele, while NAP1L4 is biallelically expressed in all the tissues except maternal expression in mouse placenta \[[@B21]\]. In the pig, CDKN1C is expected of maternal expression \[[@B22]\]. Despite of these advances, data on porcine CDKN1C and NAP1L4 are limited. Hence, tissue expression patterns and imprinting status of porcine CDKN1C and NAP1L4 were investigated in this work. This study will contribute to increasing the understanding of functional importance of CDKN1C and NAP1L4 in pigs.

2. Materials and Methods {#sec2}
========================

2.1. Tissue Samples and cDNA Preparations {#sec2.1}
-----------------------------------------

Reciprocal crossings were performed using 8 Landrace (LD) and 8 indigenous China breed Rongchang (RC) pigs (4 boars and 4 sows of each breed). These boars and sows have no common grandparents. Tissues including heart, stomach, skeletal muscle, kidney, lung, liver, small intestine, bladder, tongue, spleen, fat, ovary and placenta were collected from 23 F1 pigs, which included 10 neonatal pigs within 24 h after birth (5 pigs from three parent pairs of LD × RC and 5 pigs from three parent pairs of RC × LD) as well as 7 and 6 one-month pigs from four parent pairs of LD × RC and RC × LD, respectively. Ear tissues of parental pigs for genomic DNA isolation and genotyping of CDKN1C and NAP1L4 were also collected. Tissue samples were stored at −80°C until use.

Total RNA was isolated from frozen tissues using TRIzol reagent (Invitrogen, San Diego, USA) and treated with DNase I (TaKaRa, Japan). Reverse transcription was carried out using AMV reverse transcriptase XL (TaKaRa, Japan) and oligo(dT) primer at 42°C for 50 min, 70°C for 15 min. Both reactants with and without reverse transcriptase were used as positive and negative samples, respectively, for gene cloning and imprinting analysis.

2.2. Molecular Cloning of CDKN1C and NAP1L4 {#sec2.2}
-------------------------------------------

The cDNA sequences of human genes CDKN1C (NM_000076) and NAP1L4 (NM_005969) were used to search for available expressed sequence tags (ESTs) in the pig ESTs database using BLASTn program (<http://www.ncbi.nlm.nih.gov/BLAST/>). The homologous sequences, sharing greater than 80% identity and match of at least 100 bp, were assembled into ESTs contigs for primer design. Primer pair CDF1/R1 was used for CDKN1C, while NAF1/R1 for NAP1L4 ([Table 1](#tab1){ref-type="table"}). To obtain full-length cDNA of the two genes, 5′- and 3′-RACE were performed with SMART RACE cDNA Amplification Kit (Clontech, USA) and the RNA LA PCR Kit (TaKaRa, Japan), respectively, according to the supplier\'s instructions. For 5′-RACE, sequence-specific primers 5′CDGSP1 and 5′CDGSP2 (nested) were designed for CDKN1C, while 5′NAGSP1 and 5′NAGSP2 (nested) for NAP1L4. For 3′-RACE, sequence-specific primers, 3′NAGSP1 and 3′NAGSP2 nested were designed for NAP1L4.

Thermocycling conditions of PCR reactions were initial denaturation at 94°C for 5 min, followed by 35 cycles of denaturation at 94°C for 30 s, annealing at 53--60°C for 30 s ([Table 1](#tab1){ref-type="table"}), and extension at 72°C for 30 s, with a final extension at 72°C for 10 min. PCR products were then sequenced at commercial service (Invitrogen, Shanghai, China).

2.3. Radiation Hybrid (RH) Mapping {#sec2.3}
----------------------------------

To obtain intron sequence for RH mapping, alignment of porcine CDKN1C and NAP1L4 with human corresponding genes (NM_000076, NM_005969) was performed. According to the consensus sequences, primers INF1/R1 and INF2/R2 ([Table 1](#tab1){ref-type="table"}) were designed for amplification of CDKN1C intron 2 and NAP1L4 intron 3. Primer pairs MF1/R1 and MF2/R2 ([Table 1](#tab1){ref-type="table"}) based on the introns above were used for PCR typing of the porcine radiation hybrid (IMpRH) panel, which were kindly provided by INRA (France) \[[@B23]\]. PCR was performed in duplicate in a total volume of 10 *μ*L, containing 25 ng IMpRH DNA samples, 0.3 *μ*M of each primer, 75 *μ*M of each dNTP, 1.5 mM MgCl~2~, and 1 U Taq DNA polymerase (TaKaRa, Japan). The PCR conditions were as follows: 3 min at 94°C, followed by 35 cycles of 30 s at 94°C, 30 s at 60°C, 30 s at 72°C, and an extra 7 min extension at 72°C. In addition, PCR reactions were carried out with pig genomic DNA (as positive control) and without DNA (as negative control). The statistical analyses of the PCR results were performed with the IMpRH mapping tool accessible at <http://rhdev.toulouse.inra.fr/>. Two-point and multiple-point RH analyses were used for the identification of linkage groups using LOD score threshold of 5.0.

2.4. Heterozygous Pig Identification and Imprinting Assay {#sec2.4}
---------------------------------------------------------

SNPs of CDKN1C and NAP1L4 genes were searched via alignment of Landrace and Rongchang cDNA sequences. Genotyping was performed for single-nucleotide polymorphisms (SNPs) in each gene using genomic DNA of the 23 F1 individuals. SNPs were detected by direct sequencing of PCR products using primer pairs IJF1/R1, IJF2/R2 ([Table 1](#tab1){ref-type="table"}), for CDKN1C and NAP1L4, respectively.

The allelic expression pattern of each gene was analyzed by RT-PCR of total RNA from samples heterozygous for SNPs. PCR products by each of the primer pairs described above were then sequenced in both directions. To eliminate the possibility of genomic DNA contamination in the RT-PCR, primers *β*-actinF/R spanning intron 3 of pig *β*-actin were designed based on porcine *β*-actin (AY550069).

2.5. Quantitative Real-Time PCR {#sec2.5}
-------------------------------

Quantitative real-time PCR was performed with SYBR Premix Ex TaqTM II kit in a Bio-Rad iQ 5 machine (USA). Primers QF1/R1, QF2/R2 and QF3/R3 ([Table 1](#tab1){ref-type="table"}) were used to amplify a 136, 128, and 165 bp cDNA for CDKN1C, NAP1L4, and RPL32 (ribosomal protein L32), respectively. Melting curve analysis (60--95°C) was used for assessing amplification specificity. Total RNA extracted from each tissue sample was reverse transcribed using PrimeScript RTase and oligo(dT) (TaKaRa, Japan). Reactions were performed in triplicate in a total volume of 25 *μ*L. The reaction volume of 25 *μ*L contained 12.5 *μ*L SYBR Premix Ex Taq II (TaKaRa, Japan), 0.4 *μ*M each of primers, and 2.5 *μ*L template cDNA. A standard curve for analysis of the expression data was derived for each single gene from a serial dilution of the pool of cDNA samples. The endogenous control gene RPL32, which showed stable expression in our published data \[[@B24]\], was used. Relative expression of each gene was determined by using the 2^−ΔΔCt^ method. ANOVA analysis and multiple comparisons were applied to each gene to verify whether the expression difference between tissues or ages was significant.

3. Results {#sec3}
==========

3.1. Sequence Analysis and Localization of Porcine CDKN1C and NAP1L4 {#sec3.1}
--------------------------------------------------------------------

The full-length cDNA spanning 1171 bp was assembled for porcine CDKN1C after sequencing the PCR products of primers CDF1/R1 as well as 5′-RACE (GenBank accession no. HQ679903). Sequence analysis showed that the gene contained an open reading frame (ORF) of 786 bp (from nt 162 to nt 947 of HQ679903), encoding a 261-amino acid protein. The ORF is 79% identical in amino acid sequence and 85% identical in nucleotide sequence to human sequences (NM_000076). The full-length cDNA of NAP1L4 is 2655 bp (HQ679902) with 470 bp 5′-UTR, 1024 bp 3′-UTR, and 1161 bp ORF, which codes for 386 amino acids. The porcine NAP1L4 utilizes a polyadenylation site (ATTAAA), located at position 2617 of HQ679902. The ORF is 94% identical in amino acid sequence and 86% identical in nucleotide sequence to human sequences (NM_005969).

In human and mouse, CDKN1C and NAP1L4 genes are closely linked \[[@B8]\]. The chromosomal location of porcine CDKN1C and NAP1L4 was determined by the IMpRH panel \[[@B23]\]. The two-point analysis showed that both CDKN1C (LOD 15.78, distance 0.15 cR, and retention frequency 16%) and NAP1L4 (LOD 17.94, distance 0.11 cR, and retention frequency 19%) were closely linked to IMpRH06175, on Sus scrofa chromosome 2 (SSC2). The multiple-point analysis demonstrated that CDKN1C was linked to 311840215 (upper marker, dist 0.34 cR) and IMpRH06175 (lower marker, dist 0.14 cR), while NAP1L4 was linked to 311840215 (upper marker, dist 0.36 cR) and IMpRH06175 (lower marker, dist 0.10 cR).

3.2. Expression and Imprinting of CDKN1C {#sec3.2}
----------------------------------------

The expression patterns of porcine CDKN1C were determined by relative quantitative real-time PCR analysis with total RNAs isolated from tissues of 5 neonatal and 7 one-month hybrids of LD × RC. For each age, RNA of a tissue was used as a biological repeat. In neonatal pigs, the mRNA level of CDKN1C in placenta was amazingly high (*P* \< 0.01), while it was very low in other tissues and with no differences between them ([Figure 1(a)](#fig1){ref-type="fig"}). In one-month-old pigs, highest expression levels were observed in lung and kidney (*P* \< 0.01), followed by skeletal muscle and heart (*P* \< 0.01). Fewer CDKN1C transcripts were present in spleen, tongue, bladder, stomach, liver, fat, and small intestine (*P* \< 0.01). Interestingly, transcript levels of porcine CDKN1C were upregulated in lung and skeletal muscle, and downregulated in tongue, bladder, and small intestine (*P* \< 0.01), but no difference was seen in the other tissues after birth.

Alignment of Rongchang and Landrace sequences revealed an SNP (A/G) at position 916 of CDKN1C (HQ679903). Since the polymorphism did not provide any available RFLP site, direct sequencing of RT-PCR products was used for the discrimination of the expressed alleles. Sequencing of the PCR products revealed that three newborn pigs from RC × LD and four from LD × RC occurred to be heterozygous for the SNP, while their parental pigs were homozygous for the allele A and G, respectively. The (RC × LD) F1 pigs only expressed the Landrace allele G, and (LD × RC) F1 pigs only expressed the Rongchang A allele in placenta ([Figure 2(a)](#fig2){ref-type="fig"}) as well as in tongue, bladder, ovary, spleen, liver, skeletal muscle, stomach, and small intestine. However, biallelic expression of porcine CDKN1C was detected in lung and kidney ([Figure 2(a)](#fig2){ref-type="fig"}).

3.3. Expression and Imprinting of NAP1L4 {#sec3.3}
----------------------------------------

NAP1L4 was ubiquitously expressed in porcine tissues. In the newborn pigs, the expression level was significantly higher in placenta (*P* \< 0.01), followed by lung and skeletal muscle (*P* \< 0.05). Fewer NAP1L4 transcripts were present in spleen, tongue, bladder, ovary, liver, stomach and small intestine (*P* \< 0.05) ([Figure 1(b)](#fig1){ref-type="fig"}). In contrast, at the age of one month, highest levels of expression were observed in lung, heart, and kidney (*P* \< 0.01) and the lowest expression were detected in spleen and tongue (*P* \< 0.01). Compared with neonatal tissues, expression of porcine NAP1L4 was upregulated in heart and kidney, and downregulated in skeletal muscle (*P* \< 0.01), but no significant changes were seen in the other tissues.

A T/C SNP was detected between Rongchang and Landrace pigs at position 2461 of NAP1L4 (HQ679902). A total of five DNA samples from (RC × LD) F1 pigs and four DNA samples from (LD × RC) F1 pigs were heterozygous for this polymorphism, while their parents Landrace and Rongchang pigs were C/C and T/T homozygotes, respectively. Direct sequencing of RT-PCR products demonstrated biallelic transcription of NAP1L4 in lung, heart, kidney, tongue, bladder, ovary, spleen, liver, skeletal muscle, stomach, small intestine, and spleen of newborn pigs. The biallelic expression of porcine NAP1L4 in skeletal muscle is illustrated in [Figure 2(b)](#fig2){ref-type="fig"}.

4. Discussion {#sec4}
=============

In this study, CDKN1C and NAP1L4 genes were cloned, and their chromosome location, expression patterns, and imprinting were further analyzed for the first time in pigs. We use Rongchang and Landrace breeds for analysis of allelic expression due to the fact that F1 hybrids of the two breeds are useful for detecting imprinting of genes \[[@B25]\]. Sequence analysis showed that porcine CDKN1C and NAP1L4 have high homology with those of human in amino acid and in nucleic acid, respectively, and both genes are closely linked in the region between markers IMpRH06175 and 311840215 on SSC2, syntenic to mice distal chromosome 7 and human 11p15.5 \[[@B8]\]. These results indicate that both genes are conservative in mammals.

CDKN1C is a potent inhibitor of several G1 cyclin/CDK complexes, and its overexpression leads to cell-cycle arrest in the G1 phase \[[@B26], [@B27]\]. The biological functions and distribution of CDKN1C in tissues have been widely investigated. In human and mouse, researches have shown that CDKN1C is mostly expressed in placenta and at low levels in other tissues, while it is expressed in adult heart, brain, lung, skeletal muscle, kidney, and pancreas \[[@B28], [@B29]\]. Recently, Shukla et al. \[[@B30]\] revealed that mRNA levels of CDKN1C were altered in placenta of intrauterine growth restriction (IUGR) and alcohol-consuming dams compared to the controls; thus, they were selected as the biomarkers for IUGR and intrauterine alcohol exposure. Mutations in mouse Cdkn1c result in the appearance of large thrombotic lesions in the labyrinth zone in mouse placenta \[[@B31]\]. Our work showed that the mRNA abundance of CDKN1C was highest in porcine neonatal placenta, while its high expression levels were detected in lung and kidney of one-month-old pigs. In general, the expression pattern of porcine CDKN1C correlates well with the human and mouse gene, and the high levels in expression of CDKN1C in porcine placenta illustrate its important roles in porcine placental growth and development.

NAP1L4 has been found to be localized mainly to the cytoplasm and a minor population of them to be in the nucleus, mediating nucleosome formation \[[@B32]\]. Hu et al. \[[@B33]\] found that NAP1L4 is ubiquitously expressed, showing a threefold higher level of expression in testis than in other tissues. Interestingly, our work also showed that NAP1L4 was ubiquitously expressed in porcine tissues, but higher expression of NAP1L4 was detected in neonatal placenta than in the other tissues. As NAP1L4 mediates angiogenesis, and it is significantly higher expressed in red-feather Taiwan country chickens of high egg productions than in the subpopulations of low egg productions \[[@B34]\]. These studies indicate that the functions of NAP1L4 contribute to reproduction performance in animals and may play a role in placental functions.

There are some reports about the imprinting of CDKN1C and NAP1L4. CDKN1C is expressed from maternal allele in both human and mouse \[[@B8]\]. Mouse Nap1l4 is paternally repressed in placenta and biallelically expressed in other embryo tissues \[[@B21]\], whereas biallelic expression of human NAP1L4 can be detected in all tissues and ages tested by Higashimoto et al. \[[@B8]\]. Like in humans, NAP1L4 in pigs was biallelically expressed in all tissues detected in this study. Furthermore, our data showed maternal expression of porcine CDKN1C in heart, tongue, bladder, ovary, spleen, liver, skeletal muscle, stomach, small intestine and placenta, consistent with previous data of greater expression of CDKN1C from parthenote than from biparental samples \[[@B22]\]. The biallelic expression of CDKN1C in lung and kidney in the pig differs from monoallelic expression in the same tissues in humans. This is because the degree of imprinting is often tissue and species specific because of different epigenetic modification \[[@B35]\]. In humans and mice, it has been documented that CDKN1C imprinting is regulated by KCNQ1OT1 antisense-RNA transcript originating from intron 10 of the maternally expressed KCNQ1 (KvLQT1) gene \[[@B36]\]. A CpG island located at the promoter of KCNQ1OT1, referred to as KvDMR1 or KCNQ1 imprinting control region (ICR), is unmethylated on the paternal allele and methylated on the maternal allele, favouring expression of KCNQ1OT1 from the paternal allele that leads to the propagation of silencing of neighboring genes including CDKN1C. While the KCNQ1 ICR has not been characterized in pigs, gene order and gene structure within this cluster are highly conservative between human, mouse, chicken, and tammar \[[@B37]\]. This information lends support to the hypothesis that different epigenetic modification of KCNQ1 ICR or other mechanisms terminatie the KCNQ1OT1 transcripts in porcine lung and kidney. Further studies are needed to elucidate the mechanisms associated with biallelic expression of CDKN1C in lung and kidney of pigs.

5. Conclusions {#sec5}
==============

The full-length cDNA of porcine NAP1L4 and cDNA including 5′-UTR and ORF of porcine CDKN1C was cloned in this study. Both porcine CDKN1C and NAP1L4 were mapped on SSC2, closely linked to IMpRH06175. Imprinting analysis showed that NAP1L4 was biallelically expressed in the tissues tested, while CDKN1C was maternally expressed in tissues except lung and kidney in pigs, confirming the results by Bischoff et al. \[[@B22]\] that CDKN1C is expected of maternal expression. This study revealed a novel imprinted domain in the pig and provided data for further investigation of functional importance of porcine CDKN1C and NAP1L4.
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![Tissue expression of porcine CDKN1C (a) and NAP1L4 (b). The expression values are normalized to RPL32 and expressed as mean ± SE. Sp: spleen; Lu: lung; H: heart; K: kidney; T: tongue; B: bladder; O: ovary; Li: liver; Sm: skeletal muscle; St: stomach; Si: small intestine; P: placenta; F: fat. ABC-column means within 0 day of age bearing different superscripts differs significantly *P* \< 0.05 (lowercase) and *P* \< 0.01 (uppercase). \*\**P* \< 0.01.](JBB2012-946527.001){#fig1}

![Maternal or biallelic expression of CDKN1C (a) and NAP1L4 (b) in 0-day pigs. RC: Rongchang pigs, LD: Landrace pigs, P: placenta, L: lung, K: kidney, Sm: skeletal muscle. Arrows indicate SNP sites.](JBB2012-946527.002){#fig2}

###### 

Primer sequences and their information for porcine CDKN1C and NAP1L4 gene.

  Genes                  Primer application        Primer name                Primer sequence (5′ → 3′)   Tm (°C)                   Product size (bp)
  ---------------------- ------------------------- -------------------------- --------------------------- ------------------------- -------------------
  CDKN1C                 Gene cloning              CDF1                       TTCTACCGCGAGACGGTG          56                        776, cDNA
  CDR1                   AGCTTTACACCTTGGGACC                                                                                        
  Intron amplification   INF1                      CAAGGCGTCGAACGAGGTTC       61.4                        331, DNA                  
  INR1                   ACAAAACCGAACGCTGCTCC                                                                                       
  IMpRH                  MF1                       TGGCTCACCGCACCTCTCTCCC     60                          222, DNA                  
  MR1                    CTCCTCGTGCAGAATACATTTAG                                                                                    
  Imprinting assay       IJF1                      CTCCGTGCCCGCCTTCTACCG      66.4                        1459, DNA and 694, cDNA   
  IJR1                   AAAACCGAACGCTGCTCCGTGG                                                                                     
  5′RACE                 5′CDGSP1                  GAAATCCCTGAGTGCGGCGGCTC    60                          690, cDNA                 
  5′CDGSP2               CCACCTGCACCGTCTCGCGGTAG   60                         443, cDNA                                             
  Real-time PCR          QF1                       ACGAGGAGCTGAGTCGTGAG       60                          136, cDNA                 
  QR1                    CTGTCCACCTCGGTCCACT                                                                                        
                                                                                                                                    
  NAP1L4                 Gene cloning              NAF1                       GCAGGAGGCGTGAGGAGAT         55.2                      917, cDNA
  NAR1                   CGGGCTGAAGAAGTTGAAGA                                                                                       
  Intron amplification   INF2                      GCAGCGAAGCGAAGAATCAAC      56.6                        368, cDNA                 
  INR2                   CTCAACGTCACCCGTGATGAAC                                                                                     
  IMpRH                  MF2                       GCACGTCTCTGCTCCTGCAG       60                          196, cDNA                 
  MR2                    CACCCGTGATGAACTCCCTTC                                                                                      
  Imprinting assay       IJF2                      GGAGTGCGAGCAGCAGTGAGA      60.7                        963, cDNA                 
  IJR2                   TCAGTTACAAACGCATCGTGAGG                                                                                    
  3′RACE                 3′NAGSP1                  GGTGCACCATTGACTGGAAG       55                          1440, cDNA                
  3′NAGSP2               CGTGACGGTGAAAACCATC       55                         1409, cDNA                                            
  5′RACE                 5′NAGSP1                  CCTGCAAAGCCGCCAGAACTTGAG   60                          591, cDNA                 
  5′NAGSP2               GACTCTGAAGGAACCCCATCTG    60                         511, cDNA                                             
  Real-time PCR          QF2                       GACTGGAAGAAAGGCAAGAACG     60                          128, cDNA                 
  QR2                    GGGCTGAAGAAGTTGAAGAAGG                                                                                     
                                                                                                                                    
  RPL32                  Real-time PCR             QF3                        AGCCCAAGATCGTCAAAAAG        60                        165, cDNA
  QR3                    TGTTGCTCCCATAACCAATG                                                                                       
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